To investigate the significance of electroencephalogram (EEG) discharges and their treatment, we retrospectively reviewed the charts of 22 children with atypical cognitive development that did not respond to standard educational therapy and demonstrated discharges on EEG. Most children demonstrated no obvious symptoms of seizures, and developmental regression and/or fluctuations were uncommon. The majority of children demonstrated a language and attention disorder and autism symptomatology and had multifocal discharges on EEGs. Of the 20 patients treated with antiepileptic medications, 70% demonstrated definite improvement within 1 clinic visit. This study suggests that children with EEG discharges and developmental cognitive disorders demonstrate a unique pattern of symptomatology and discharges on EEG. This study suggests that children with developmental cognitive disorders that do not respond to standard therapy may benefit from screening with an EEG and a trial of antiepileptic mediation if discharges are detected.
The significance of electroencephalogram (EEG) discharges on cognitive and behavioral development has been debated. Electroencephalogram discharges have a high incidence in several neurodevelopmental disorders, such as autism spectrum disorder and Asperger syndrome, even when a diagnosable seizure disorder is absent. 1, 2 This has led some to suggest that these discharges could be correlated with abnormal behavioral and cognitive development. However, discharges are commonly found in children who have benign childhood epileptic disorders such as benign rolandic epilepsy of childhood. Children with benign rolandic epilepsy of childhood, for the most part, demonstrate normal cognitive development despite frequent discharges on the EEG. This has raised doubt regarding the association of discharges with abnormal behavioral and/ or cognitive development.
In some cases, benign rolandic epilepsy of childhood can be associated with cognitive disturbances. 3, 4 Several reports have examined cases with electroencephalographic characteristics of benign rolandic epilepsy of childhood, who also have cognitive or achievement deficits. 5 Using magnetoencephalography, studies have suggested that discharge location may be related to specific behavioral and cognitive abnormalities. Wolff et al 6 demonstrated that children with discharges in the left perisylvian area scored lower in tests of language, whereas children with discharges in the occipital cortex scored lower in tests involving visual transformation. Such data are consistent with a larger study by Lewine et al, 7 who demonstrated that children with traditional Landau-Kleffner syndrome demonstrated primary discharges only in the left temporoparietal area. Lewine et al 7 also demonstrated that children with pervasive developmental disorder demonstrated additional discharges outside the left temporoparietal area and manifested a multifocal pattern of discharges.
Several studies have demonstrated that a subset of children with developmental disorders manifest abnormal electroencephalographic studies, and in some studies, abnormal EEGs were reported to be more likely in children with cognitive regression. 8 However, studies have not examined whether children with discharges, as a group (1) represent a specific clinical phenotype, (2) manifest a specific electroencephalographic pattern, or (3) respond to antiepileptic drug treatment. Identifying neurological or cognitive characteristics that are specific to children with electroencephalographic discharges would help determine which children require an EEG to identify discharges. Identifying specific electroencephalographic characteristics of discharges would be of great value for identifying candidates in whom discharges may be associated with abnormal cognitive and behavioral development. Documenting significant improvement in cognition with initiation of antiepileptic drug treatment would help validate the notion that EEG discharges are clinically significant and treatable.
In this study, we investigate a series of children who presented to our pediatric neurology clinic with cognitive delays, including abnormalities of speech, social function, attention, learning, or memory, and who did not respond to standard educational interventions, and who demonstrated discharges on EEG. All children had more than 2 EEGs allowing us to compare the consistency in electroencephalographic findings across studies. To address the lack of information on EEG discharges, as outlined above, we (1) reviewed the presenting and general cognitive symptoms, (2) examined the consistency in electroencephalographic findings and correlated the discharges with cognitive symptoms, and (3) determined whether antiepileptic drug treatment was associated with cognitive improvement.
Methods

Participants presented to the University of Texas Health Science
Center at Houston Child and Adolescent Neurology Clinic for evaluation. One of the first 2 authors evaluated patients with a neurological history and physical examination. Specific questions addressed cognitive development, any developmental regression and fluctuations, and signs of seizures including staring episodes and other subtle episodes of seizures. Specific information was abstracted from independent educational, psychological, or neuropsychological evaluations. Specifically, it was determined whether the patients met criteria for developmental disorders in receptive and expressive language, reading, and/or attention. An evaluation for delays in social development, including symptoms related to autism spectrum disorder, was abstracted from the outside evaluations and conducted by the examiner using Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) criteria. For patients who had an intellectual quotient determined, none were in the mental retardation range.
All patients underwent at least 2 EEG studies. Studies included routine EEGs, outpatient ambulatory EEGs, and 23-hour continuous videoelectroencephalographic monitoring in the epilepsy monitoring unit at Children's Memorial Hermann Hospital, Houston, Texas. The international 10-20 electrode placement system was used for all EEGs but sedation was not. A board-certified epileptologist read all EEGs. Additional EEGs were ordered depending on the clinical course of the child and electroencephalographic type was guided by standard clinical judgment. All patients underwent magnetic resonance imaging (MRI) using epilepsy and focal cortical dysplasia protocols.
In all, 12 children (55%) underwent magnetic source imaging (4-D Neuroimaging, San Diego, California). Sources of magnetoencephalographic activity were modeled as single equivalent current dipoles, and their locations were estimated and projected onto the patient's MRI for epileptiform dipole localization. An EEG was conducted as part of the magnetoencephalography protocol.
Initiation of antiepileptic drug therapy was offered to all patients during their clinical evaluation. The timing of the initiation of therapy was a combination of clinical recommendations and the parents' wishes. The decision whether to initiate an antiepileptic drug and whether to perform the initial EEG followed a general guideline. Younger patients (N ¼ 11; mean age, 5 years 0 months; SD, 10 months) were first prescribed standardized educational therapy and followed clinically for several months to years (mean, 1 year 6 months; SD, 4 months) to determine whether they would respond to such therapy before antiepileptic medication was prescribed. Older patients (N ¼ 9; mean age, 9 years 2 months; SD 3, years 9 months) who had several years of educational therapy despite no improvement were prescribed antiepileptic medication upon a positive EEG study.
The particular antiepileptic drug chosen was determined in consultation with parents after discussing the risks and benefits of each antiepileptic drug. The patient's treatment response in cognition was assessed in an unblinded manner by the parents, educators, and/or therapists as well as the clinician. A 5-point scale was used to assess treatment response: 1 ¼ definite improvement, 2 ¼ possible improvement, 3 ¼ no change, 4 ¼ possible worsening, and 5 ¼ definite worsening. All parties assessing the child (ie, parents, educators, therapists, and clinician) needed to agree on improvement. If the parties did not agree, the worst response was recorded. Lack of improvement typically resulted in change in antiepileptic drug therapy and/or repeat EEG. Comorbid attention disorders were treated with standardized medications, usually amphetamine salts.
The study was conducted in accordance with the Institutional Review Board regulations for the protection of human participants of our institution.
Results
Patient Characteristics
There were slightly more male (55%) than female children (45%). Age of presentation ranged from 1 year 11 months to 11 years 1 month with an average age of 5 years 11.5 months (SD, 2 years 9.8 months). Only 9% had a history of seizures and 4.5% had a history of an abnormal EEG. Twenty-six percent of MRI scans were abnormal with left hippocampus abnormalities accounting for 80% (Appendix Table A ).
Presenting Complaint
The most common presenting complaint was speech and/or language disorder (68%), with few of these patients admitting to language regression (7%) or fluctuation (20%). Learning disability, including reading disability, was the second most common presenting complaint (23%) with few of these patients admitting to fluctuations (20%). Memory problems, including word finding difficulties, was the third most common presenting complaint (18%) with half describing fluctuation. Eighteen percent presented with atypical paroxysmal symptoms and 1 patient presented with more classic episodes of seizures (see Appendix Table A and Table 1 ).
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Comorbid Cognitive Disorders
Attention problems were the common comorbid disorder (73%) with 25% of these patients having mild attention problems that did not qualify for attention-deficit disorder with or without hyperactivity and 75% having moderate-to-severe attention problems that qualified for the attention-deficit disorder with or without hyperactivity diagnosis. At least 1 symptom of autism was present in 59% of patients with 8% of these patients demonstrating echolalia, 46% being diagnosed with mild pervasive developmental disorder, 23% diagnosed with pervasive developmental disorder-not otherwise specified, and 8% diagnosed with high-functioning autism. Of the 7 children that did not present with a speech or language disorder, 71% had a history of speech or language disorder. Overall, 91% of patients had a history of a speech or language disorder ( Table 2) . Of the patients not presenting with paroxysmal episodes, 53% were found to have subtle symptoms of paroxysms, with staring episodes being the most common symptom. Of all patients, 64% were found to have paroxysmal episodes either on presentation or on detailed questioning.
Electroencephalograms: Relationship Between Abnormalities and Electroencephalogram Type
A total of 82 EEG studies were performed across all patients. Most (77%) initial EEGs demonstrated discharges. Normal initial studies were found in 29% of routine EEGs, 33% of the ambulatory electroencephalographic studies, and 0% of epilepsy monitoring unit studies. When the patient was not receiving antiepileptic medications, discharges were present on epilepsy monitoring unit studies and on EEGs performed during magnetoencephalography 100% of the time, while discharges were less likely on routine EEGs (74%) and ambulatory EEGs (63%). Of the abnormal EEGs, sharp wave was the predominant discharge type (61%), whereas focal spike and slow wave (10%) and spike and wave (8%) occurred less often. Focal (11%) and generalized (7.5%) slowing were also seen. A clinical correlation with the EEG discharges was only detected in 1 patient. This represents a clinical correlation in 1% of all electroencephalographic studies and 2% of all extended studied electroencephalographic studies.
Electroencephalogram: Discharge Lateralization and Localization Consistency
Most patients (86%) demonstrated discharges on at least 2 EEG studies. Of these patients, 95% demonstrated focal or multifocal discharges consistently. Consistent lateralization of focal or multifocal discharges was only seen in 53% of these patients or in 45% of patients overall. Of the patients who demonstrated consistent lateralization of focal or multifocal discharges, most (60%, or 27% of all patients) demonstrated bilateral discharges. Overall, only 25% of the patients demonstrated consistent discharge localization.
Electroencephalogram Discharge Lateralization: Correlation With Symptoms
Here we consider the 10 patients who demonstrated consistent lateralization of discharges. The patient with pervasive developmental disorder demonstrated right hemisphere discharges. Of the 4 patients with attention-deficit hyperactivity disorder (ADHD), 3 demonstrated bilateral discharges and 1 demonstrated right hemisphere discharges. Of the 2 patients with a diagnosis of reading disability, 1 demonstrated right hemisphere discharges, while the other demonstrated bilateral discharges. Of the 4 patients with isolated speech disorder, half had left hemisphere discharges while the others demonstrated bilateral discharges.
Magnetoencephalography Discharge Localization and Correlation With Symptoms
Source localization of magnetoencephalography spikes was performed in 12 patients but 1 patient demonstrated no discharges and another demonstrated inconsistent findings over 2 magnetoencephalography scans. The remaining 10 patients were considered. The 2 patients diagnosed with pervasive 
Antiepileptic Treatment
Appendix Table D outlines each patient's clinical course and their response to antiepileptic treatment. Overall, 91% of the patients were treated with antiepileptic drugs. Of these, 15% also were prescribed stimulants. Most patients were only treated with 1 antiepileptic drug, while 20% required a second antiepileptic drug trial and 5% required a third antiepileptic drug trial. One child was concurrently treated with 2 antiepileptic drugs. Antiepileptic medications were changed or added for several reasons: no improvement or limited improvement was seen with treatment (N ¼ 2); definite improvement occurred in some areas of cognition, but other areas of cognition and behavior were still below what would be expected for age (N ¼ 3); and regression occurred approximately 10 months after response to a low dose of an antiepileptic medication (N ¼ 1). The distribution of the antiepileptic drugs is outlined in Table 3 . Table 4 outlines the clinical response to antiepileptic drug treatment. Overall, most (80%) patients responded to antiepileptic drug treatment either initially or after increasing the antiepileptic drug dose. Of the 2 patients not treated with antiepileptic drugs, development eventually improved in 1, while in the other, it did not. Although we do not have a control group, 55% of the patients treated with antiepileptic medications were followed untreated for months to years before initiation of antiepileptic therapy, thus providing a partial crossover control group. As seen in Table 4 , most (81%) of these patients improved with antiepileptic drug treatment, either initially or after an increase in antiepileptic drug dose. Antiepileptic drug treatment was withdrawn in 2 patients who initially responded significantly. Both patients developed significant regression following antiepileptic drug withdrawal and improved with reinstituting the antiepileptic drug.
We examined the change in EEG with change in clinical response to antiepileptic treatment. This was complicated because most EEGs were performed several years after response to antiepileptic medication to determine whether the child could be discontinued from the antiepileptic medication or in some cases when the child had a regression following withdrawal of the antiepileptic medication. Electroencephalograms were performed on 11 children who definitely responded clinically while they were on medication and demonstrated clinical improvement. Of these children, 64% of these children demonstrated normalization of the EEG while 18% demonstrated improvement in discharge frequency on the EEG and 18% demonstrated no improvement in the number of discharges on the EEG. Of the 2 patients that did not demonstrate definite clinical response, the EEG normalized for 1, while the other did not show any significant change in discharges.
Discussion
We have reviewed a case series of 22 patients with developmental cognitive disorders that were refractory to standard educational interventions, who were subsequently found to have EEG discharges. Most of these children were treated with antiepileptic drugs in an open-labeled manner. We use this review to answer 3 important questions.
Do Children With EEG Discharges Demonstrate a Specific Clinical Phenotype?
Our sample demonstrates distinct characteristics. First, unlike idiopathic speech, language, or reading disability, we do not find a particular male prevalence. Second, although the average age of presentation was almost 6 years, somewhat later than Landau-Kleffner syndrome, several children presented considerably younger than 3 years of age. Third, very few children presented with or had a history of paroxysmal episodes, and of the remainder, only about half admitted to subtle paroxysmal symptoms. For those children that presented with cognitive disturbances, few admitted to regression or fluctuations. Thus, although these classic paroxysmal symptoms are important to elicit in the history, the lack of these symptoms does not rule out potentially clinically significant discharges. Fourth, although most anatomic MRI scans were normal, subtle left hippocampus abnormalities, mostly mild atrophy, were found in several of the patients, suggesting that this finding may be significant, if found. Review of these patients demonstrated that their symptomatology or electroencephalographic characteristics were not different from other patients. Fifth, the great majority of the patients (91%), whether or not it was their presenting complaint, had a speech or language disorder. Sixth, a high proportion of children (73%) had attention problems, with over half (55%) of the children having symptoms severe enough to meet criteria for attention deficit with or without hyperactivity disorder. Seventh, the majority of the patients (59%) demonstrated some core autism symptoms, although most of the time these were limited and did not substantiate a diagnosis of autism disorder. Thus, this study seems to substantiate a unique clinical phenotype associated with electroencephalographic discharges. The patients in our study demonstrate a history of speech or language disorder with clear symptoms of attention difficulties and some, but not many, symptoms of autism. Classic epileptic encephalopathies, specifically Landau-Kleffner syndrome and continuous spike and wave during slow wave during sleep, are characterized by status epilepticus during sleep, regression in receptive language after 3 years of age, and behavioral comorbidities that include hyperactivity, aggressiveness, and depression. 9,10 Clearly the patients described in this study have similarities and differences with these classic syndromes.
Is There an EEG Discharge Signature?
Focal discharges on at least 2 EEGs were seen in the great majority of the patients (82%). However, consistent discharge lateralization was only seen in 45% of the overall sample, and only 17% of the patients demonstrated lateralization to a single hemisphere. Although we attempted to correlate discharge lateralization with symptomatology, the inconsistency in discharge lateralization resulted in a small number of patients on which to base this evaluation, making it difficult to make any conclusions. The fact that most discharges were focal (79%) but were either inconsistently lateralized to a hemisphere or consistently found to be bilateral suggests a multifocal discharge pattern. This is substantiated by the magnetoencephalography data that demonstrate bilateral discharges in several patients and inconsistent lateralization in 1 patient across 2 studies. These data are consistent with Lewine et al, 7 who demonstrated that children with pervasive developmental disorder demonstrated multifocal neuromagnetic discharges.
Does Treatment of Discharges With Antiepileptic Drugs Influence Development?
Treatment of children with electroencephalographic discharges is controversial, most likely because of the fact that the significance of such discharges is unclear, resulting in an unclear risk to benefit ratio. This is underscored by the fact that children with Landau-Kleffner syndrome, a related disorder with a more definite association between discharges and cognitive disability, do not typically respond robustly to standard antiepileptic drug treatment. 9,10 A great majority of patients whom we offered an antiepileptic drug trial responded robustly. A smaller number responded only after increasing the antiepileptic drug dose. Two patients underwent regression with withdrawal of the antiepileptic drug treatment, further substantiating the utility of antiepileptic drug treatment by rechallenge methodology. Interestingly, discharges did not always disappear with antiepileptic treatment. This parallels our clinical experience. It is possible that this represents children who have responded to antiepileptic medications as a placebo. It is also possible that the antiepileptic medication has limited the spread of the discharges to other cortical areas, thereby reduced electrographic disturbance in important adjacent cortical regions. Overall, these data provide intriguing findings that warrant further study.
Study Limitations
This study was not designed to be a prevalence study, thus it is unknown how many children with developmental challenges are affected clinically by electroencephalographic discharges. The sample of patients evaluated in this study was subject to referral bias. Furthermore, although we tried to apply a standard criterion to all patients for electroencephalographic screening, the decision to screen and treat the child was performed in collaboration with the child's parents. This might suggest that the parents who accepted the protocol were more likely to expect the protocol to have a positive effect. This raises the possibility of a significant placebo effect. However, the positive effect of antiepileptic drugs was markedly larger than the 19% placebo effect 11 in antiepileptic drug studies examining children, and many children improved only with antiepileptic drug treatment despite being followed for many years. Clearly, a prospective double-blind placebo controlled study with objective language assessments will be needed to validate the treatment data presented. Such an effort would be important and significant, because if simple antiepileptic drug treatment could positively affect selected children, such treatment could have a substantial impact on the most difficult to treat children.
Conclusions
In this article, we have reviewed a case series of 22 patients with EEG discharges and developmental cognitive disorders that were refractory to standard educational interventions. As a group, these children appear to have a distinct behavioral and cognitive phenotype characterized by language delay, moderate-to-severe attention difficulties, and autism symptoms. Regression and fluctuation in cognition and symptoms of seizures, even subtle symptoms, were not common. As a group, these children appeared to respond positively to antiepileptic drugs. Although this study is limited in its design, these preliminary data suggest that there is a subpopulation of children that are refractory to standard educational treatment, who may benefit from referral to a pediatric neurologist for further evaluation and an electroencephalographic study to identify discharges. The great majority of the patients that we studied did not have confirmed clinical or electrographic seizures. Without a documented seizure, it is not clear whether these children fall into an epileptiform or encephalopathy syndrome. Future studies to determine which subset of children with discharges may benefit from antiepileptic drug treatment will be critical, because long-term treatment with some antiepileptic drugs may result in adverse cognitive and psychiatric effects. 12 AA, auditory agnosia; WFD, word finding difficulties; MRELD, mixed receptive-expressive language disorder; ELD, expressive language disorder; SID, sensory integration disorder; SD, speech delay; GMD, gross motor delay; FMD, fine motor delay; RD, dyslexia; LD, learning disability-NOS; MD, math disability; APD, auditory processing disorder; HFASD, high-functioning autism spectrum disorder. SD Mild, Echolalia ADHD-C 5.
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